Type of Assessment:
Risk Assessment
Title:
Open For Comments:
Dec 15, 2017, 1:00 AM
Comments Due:
Mar 15, 2018, 12:00 AM
Summary:
This notice announces the availability of EPA's draft human health and ecological risk assessments for the registration review of abamectin, buprofezin, chlorpropham, emamectin benzoate, fludioxonil, fluopicolide, fluridone, methiocarb, norflurazon, oryzalin, PBO (piperonyl buotoxide), pyriproxyfen, and quinoxyfen. This notice also announces the availability of EPA's draft human health risk assessments for the registration review of 2,4-D, bifenthrin, and cyfluthrins.